BIORA THERAPEUTICS, INC. (BIOR) Revenues USD 2020 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Biora Therapeutics, Inc. quarterly/annual Revenues history and growth rate from 2020 to 2022.
  • Biora Therapeutics, Inc. Revenues for the quarter ending December 31, 2022 was -$88 K, a 101% decline year-over-year.
  • Biora Therapeutics, Inc. Revenues for the twelve months ending December 31, 2022 was $12.2 M, a 79.9% decline year-over-year.
  • Biora Therapeutics, Inc. annual Revenues for 2022 was $12.2 M, a 79.9% decline from 2021.
  • Biora Therapeutics, Inc. annual Revenues for 2021 was $60.6 M, a 18.4% decline from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $12.2 M -$88 K -$7.75 M -101% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $19.9 M $10 M +$285 K +2.93% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $19.6 M $863 K -$17.8 M -95.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $37.5 M $1.38 M -$23.2 M -94.4% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $60.6 M $7.66 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $9.72 M -$16.2 M -62.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $18.7 M +$1.44 M +8.33% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $24.5 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $25.9 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $17.3 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.